Ovid Therapeutics Stock Price Prediction

OVID Stock  USD 3.05  0.05  1.67%   
The RSI of Ovid Therapeutics' share price is below 30 at the present time. This indicates that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Ovid Therapeutics, making its price go up or down.

Oversold Vs Overbought

26

 
Oversold
 
Overbought
Ovid Therapeutics stock price prediction is an act of determining the future value of Ovid Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Ovid Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Ovid Therapeutics and does not consider all of the tangible or intangible factors available from Ovid Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Ovid Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Ovid Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.18)
EPS Estimate Current Year
(0.86)
EPS Estimate Next Year
(0.23)
Wall Street Target Price
7.2
EPS Estimate Current Quarter
(0.05)
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Ovid Therapeutics based on different types of headlines from major news networks to social media. The Ovid stock price prediction module provides an analysis of price elasticity to changes in media outlook on Ovid Therapeutics over a specific investment horizon. Using Ovid Therapeutics hype-based prediction, you can estimate the value of Ovid Therapeutics from the perspective of Ovid Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Ovid Therapeutics using Ovid Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Ovid using crowd psychology based on the activity and movement of Ovid Therapeutics' stock price.

Ovid Therapeutics Implied Volatility

    
  0.0  
Ovid Therapeutics' implied volatility exposes the market's sentiment of Ovid Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Ovid Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Ovid Therapeutics stock will not fluctuate a lot when Ovid Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Ovid Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Ovid Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Ovid because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Ovid Therapeutics after-hype prediction price

    
  USD 3.05  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Ovid Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ovid Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.393.767.13
Details
Naive
Forecast
LowNextHigh
0.073.316.68
Details
6 Analysts
Consensus
LowTargetHigh
5.696.256.94
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.24-0.22-0.2
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ovid Therapeutics. Your research has to be compared to or analyzed against Ovid Therapeutics' peers to derive any actionable benefits. When done correctly, Ovid Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Ovid Therapeutics.

Ovid Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Ovid Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ovid Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ovid Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Ovid Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Ovid Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ovid Therapeutics' historical news coverage. Ovid Therapeutics' after-hype downside and upside margins for the prediction period are 0.15 and 6.42, respectively. We have considered Ovid Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.05
3.05
After-hype Price
6.42
Upside
Ovid Therapeutics is relatively risky at this time. Analysis and calculation of next after-hype price of Ovid Therapeutics is based on 3 months time horizon.

Ovid Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Ovid Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ovid Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ovid Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.03 
3.37
 0.00  
  0.01 
6 Events / Month
3 Events / Month
In about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.05
3.05
0.00 
6,740  
Notes

Ovid Therapeutics Hype Timeline

Ovid Therapeutics is now traded for 3.05. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Ovid is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.03%. %. The volatility of related hype on Ovid Therapeutics is about 1949.59%, with the expected price after the next announcement by competition of 3.04. About 16.0% of the company outstanding shares are owned by corporate insiders. The book value of Ovid Therapeutics was now reported as 1.24. The company recorded a loss per share of 0.74. Ovid Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days.
Check out Ovid Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.

Ovid Therapeutics Related Hype Analysis

Having access to credible news sources related to Ovid Therapeutics' direct competition is more important than ever and may enhance your ability to predict Ovid Therapeutics' future price movements. Getting to know how Ovid Therapeutics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ovid Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ATSGAir Transport Services(0.34)9 per month 0.00 (0.16) 4.13 (4.67) 9.10 
CPACopa Holdings SA(0.16)11 per month 0.00 (0.09) 2.87 (2.78) 6.70 
AALAmerican Airlines Group 0.18 7 per month 2.33  0.0005  4.59 (3.65) 16.66 
SKYWSkyWest(0.89)11 per month 0.97  0.20  2.94 (2.23) 10.40 
MRRTYMarfrig Global Foods 0.00 0 per month 0.00 (0.06) 5.71 (4.92) 14.40 
AGZNFAegean Airlines SA 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NIPMYNH Foods 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Ovid Therapeutics Additional Predictive Modules

Most predictive techniques to examine Ovid price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ovid using various technical indicators. When you analyze Ovid charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Ovid Therapeutics Predictive Indicators

The successful prediction of Ovid Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ovid Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ovid Therapeutics based on analysis of Ovid Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ovid Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ovid Therapeutics's related companies.
 2010 2023 2024 (projected)
Interest Coverage20.1218.1116.1
Total Debt To Capitalization0.110.260.15

Story Coverage note for Ovid Therapeutics

The number of cover stories for Ovid Therapeutics depends on current market conditions and Ovid Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ovid Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ovid Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Ovid Therapeutics Short Properties

Ovid Therapeutics' future price predictability will typically decrease when Ovid Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ovid Therapeutics often depends not only on the future outlook of the potential Ovid Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ovid Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding70.6 M
Cash And Short Term Investments105.8 M
When determining whether Ovid Therapeutics is a strong investment it is important to analyze Ovid Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ovid Therapeutics' future performance. For an informed investment choice regarding Ovid Stock, refer to the following important reports:
Check out Ovid Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Ovid Stock analysis

When running Ovid Therapeutics' price analysis, check to measure Ovid Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ovid Therapeutics is operating at the current time. Most of Ovid Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ovid Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ovid Therapeutics' price. Additionally, you may evaluate how the addition of Ovid Therapeutics to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Is Ovid Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ovid Therapeutics. If investors know Ovid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ovid Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.74)
Revenue Per Share
0.006
Quarterly Revenue Growth
2.059
Return On Assets
(0.25)
Return On Equity
(0.48)
The market value of Ovid Therapeutics is measured differently than its book value, which is the value of Ovid that is recorded on the company's balance sheet. Investors also form their own opinion of Ovid Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Ovid Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ovid Therapeutics' market value can be influenced by many factors that don't directly affect Ovid Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ovid Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ovid Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ovid Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.